122 related articles for article (PubMed ID: 28271374)
1. Self-Stabilizing Ampholytic Starch Excipients for Sustained Release of Highly Soluble Drugs: the Case Study of Metformin.
Sakeer K; Ispas-Szabo P; Mateescu MA
AAPS PharmSciTech; 2017 Oct; 18(7):2658-2672. PubMed ID: 28271374
[TBL] [Abstract][Full Text] [Related]
2. Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
Sakeer K; Ispas-Szabo P; Benyerbah N; Mateescu MA
Int J Pharm; 2018 Jan; 535(1-2):201-216. PubMed ID: 29128422
[TBL] [Abstract][Full Text] [Related]
3. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.
Mulhbacher J; Ispas-Szabo P; Lenaerts V; Mateescu MA
J Control Release; 2001 Sep; 76(1-2):51-8. PubMed ID: 11532312
[TBL] [Abstract][Full Text] [Related]
4. Ampholytic and Polyelectrolytic Starch as Matrices for Controlled Drug Delivery.
Benyerbah N; Ispas-Szabo P; Sakeer K; Chapdelaine D; Mateescu MA
Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159403
[TBL] [Abstract][Full Text] [Related]
5. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl Starch Excipients for Drug Chronodelivery.
Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
[TBL] [Abstract][Full Text] [Related]
7. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
Assaad E; Mateescu MA
Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dibutyrylchitin as new excipient for sustained drug release.
Casettari L; Cespi M; Castagnino E
Drug Dev Ind Pharm; 2012 Aug; 38(8):979-84. PubMed ID: 22124336
[TBL] [Abstract][Full Text] [Related]
9. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
[TBL] [Abstract][Full Text] [Related]
10. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
11. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
12. Cross-linked high amylose starch derivatives for drug release III. Diffusion properties.
Mulhbacher J; Mateescu MA
Int J Pharm; 2005 Jun; 297(1-2):22-9. PubMed ID: 15878244
[TBL] [Abstract][Full Text] [Related]
13. Design of Catalase Monolithic Tablets for Intestinal Targeted Delivery.
Alothman M; Ispas-Szabo P; Mateescu MA
Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33430270
[TBL] [Abstract][Full Text] [Related]
14. Anthocyanins Formulated with Carboxymethyl Starch for Gastric and Intestinal Delivery.
De Sousa Sabino LB; Copes F; Saulais S; De Brito ES; Da Silva Júnior IJ; Le TC; Mateescu MA; Mantovani D
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364096
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive properties of cross-linked high amylose starch derivatives.
Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
[TBL] [Abstract][Full Text] [Related]
16. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
Mulhbacher J; Ispas-Szabo P; Mateescu MA
Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
[TBL] [Abstract][Full Text] [Related]
17. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
18. Anionic and Ampholytic High-Amylose Starch Derivatives as Excipients for Pharmaceutical and Biopharmaceutical Applications: Structure-Properties Correlations.
Labelle MA; Ispas-Szabo P; Tajer S; Xiao Y; Barbeau B; Mateescu MA
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986695
[TBL] [Abstract][Full Text] [Related]
19. Recent advances of starch-based excipients used in extended-release tablets: a review.
Hong Y; Liu G; Gu Z
Drug Deliv; 2016; 23(1):12-20. PubMed ID: 24833274
[TBL] [Abstract][Full Text] [Related]
20. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
